Share

March 2017; 4 (2)

Share

A

  1. Agirrezabal, Ion

    1. Open Access
      Metabolomic signatures associated with disease severity in multiple sclerosis
      Pablo Villoslada, Cristina Alonso, Ion Agirrezabal, Ekaterina Kotelnikova, Irati Zubizarreta, Irene Pulido-Valdeolivas, Albert Saiz, Manuel Comabella, Xavier Montalban, Luisa Villar, Jose Carlos Alvarez-Cermeño, Oscar Fernández, Roberto Alvarez-Lafuente, Rafael Arroyo, Azucena Castro

  2. Agrawal, Brajesh K.

    1. Open Access
      Characteristics and pharmacodynamics of severe neuroinflammation in a child with neurolupus
      Michael R. Pranzatelli, Nathan R. McGee, Zeng Y. Wang, Brajesh K. Agrawal

  3. Aguilar, Jenner

    1. Open Access
      Validity of a PCR assay in CSF for the diagnosis of neurocysticercosis
      Arturo Carpio, Alfredo Campoverde, Matthew L. Romo, Lorena García, Luis M. Piedra, Mónica Pacurucu, Nelson López, Jenner Aguilar, Sebastian López, Luis C. Vintimilla, Ana M. Toral, Pablo Peña-Tapia

  4. Akaishi, Tetsuya

    1. Open Access
      MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsy
      Ryo Ogawa, Ichiro Nakashima, Toshiyuki Takahashi, Kimihiko Kaneko, Tetsuya Akaishi, Yoshiki Takai, Douglas Kazutoshi Sato, Shuhei Nishiyama, Tatsuro Misu, Hiroshi Kuroda, Masashi Aoki, Kazuo Fujihara

  5. Alonso, Cristina

    1. Open Access
      Metabolomic signatures associated with disease severity in multiple sclerosis
      Pablo Villoslada, Cristina Alonso, Ion Agirrezabal, Ekaterina Kotelnikova, Irati Zubizarreta, Irene Pulido-Valdeolivas, Albert Saiz, Manuel Comabella, Xavier Montalban, Luisa Villar, Jose Carlos Alvarez-Cermeño, Oscar Fernández, Roberto Alvarez-Lafuente, Rafael Arroyo, Azucena Castro

  6. Alvarez-Cermeño, Jose Carlos

    1. Open Access
      Metabolomic signatures associated with disease severity in multiple sclerosis
      Pablo Villoslada, Cristina Alonso, Ion Agirrezabal, Ekaterina Kotelnikova, Irati Zubizarreta, Irene Pulido-Valdeolivas, Albert Saiz, Manuel Comabella, Xavier Montalban, Luisa Villar, Jose Carlos Alvarez-Cermeño, Oscar Fernández, Roberto Alvarez-Lafuente, Rafael Arroyo, Azucena Castro

  7. Alvarez-Lafuente, Roberto

    1. Open Access
      Metabolomic signatures associated with disease severity in multiple sclerosis
      Pablo Villoslada, Cristina Alonso, Ion Agirrezabal, Ekaterina Kotelnikova, Irati Zubizarreta, Irene Pulido-Valdeolivas, Albert Saiz, Manuel Comabella, Xavier Montalban, Luisa Villar, Jose Carlos Alvarez-Cermeño, Oscar Fernández, Roberto Alvarez-Lafuente, Rafael Arroyo, Azucena Castro

  8. Aoki, Masashi

    1. Open Access
      MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsy
      Ryo Ogawa, Ichiro Nakashima, Toshiyuki Takahashi, Kimihiko Kaneko, Tetsuya Akaishi, Yoshiki Takai, Douglas Kazutoshi Sato, Shuhei Nishiyama, Tatsuro Misu, Hiroshi Kuroda, Masashi Aoki, Kazuo Fujihara

  9. Arroyo, Rafael

    1. Open Access
      Metabolomic signatures associated with disease severity in multiple sclerosis
      Pablo Villoslada, Cristina Alonso, Ion Agirrezabal, Ekaterina Kotelnikova, Irati Zubizarreta, Irene Pulido-Valdeolivas, Albert Saiz, Manuel Comabella, Xavier Montalban, Luisa Villar, Jose Carlos Alvarez-Cermeño, Oscar Fernández, Roberto Alvarez-Lafuente, Rafael Arroyo, Azucena Castro

  10. Ashtamker, Natalia

    1. Open Access
      Time course of glatiramer acetate efficacy in patients with RRMS in the GALA study
      Mat D. Davis, Natalia Ashtamker, Joshua R. Steinerman, Volker Knappertz

  11. Auer, Michael

    1. Open Access
      Severe early natalizumab-associated PML in MS: Effective control of PML-IRIS with maraviroc
      Gabriel Bsteh, Michael Auer, Sarah Iglseder, Lisa-Maria Walchhofer, Dietmar Langenscheidt, Stefan Koppi, Gabriele Schauer-Maurer, Guenther Stockhammer, Thomas Berger

B

  1. Barragán-Martínez, Diego

    1. Open Access
      Delayed tacrolimus leukoencephalopathy, a rare and reversible cause of dementia
      Diego Barragán-Martínez, Ana Simarro-Díaz, Patricia Calleja-Castaño, Aurelio Hernández-Laín, Ana Ramos-González, Alberto Villarejo-Galende

  2. Becker, Veit

    1. Open Access
      Maraviroc as possible treatment for PML-IRIS in natalizumab-treated patients with MS
      Sibylle C. Hodecker, Klarissa H. Stürner, Veit Becker, Birte Elias-Hamp, Brigitte Holst, Manuel A. Friese, Christoph Heesen

  3. Benninger, Felix

    1. Open Access
      Maraviroc in PML-IRISA separate ball game under HIV infection and natalizumab?
      Israel Steiner, Felix Benninger

  4. Berger, Thomas

    1. Open Access
      Severe early natalizumab-associated PML in MS: Effective control of PML-IRIS with maraviroc
      Gabriel Bsteh, Michael Auer, Sarah Iglseder, Lisa-Maria Walchhofer, Dietmar Langenscheidt, Stefan Koppi, Gabriele Schauer-Maurer, Guenther Stockhammer, Thomas Berger

  5. Bertolotto, Antonio

    1. Open Access
      Aquaporin-4 antibody titration in NMO patients treated with rituximabA retrospective study
      Paola Valentino, Fabiana Marnetto, Letizia Granieri, Marco Capobianco, Antonio Bertolotto

  6. Berzero, Giulia

    1. Open Access
      Paraneoplastic cerebellar degeneration associated with anti-ITPR1 antibodies
      Giulia Berzero, Yael Hacohen, Lars Komorowski, Madeleine Scharf, Caroline Dehais, Delphine Leclercq, Virginie Fourchotte, Bruno Buecher, Jérôme Honnorat, Francesc Graus, Jean-Yves Delattre, Dimitri Psimaras

  7. Bill, Pierre L.A.

    1. Open Access
      A comparative study of CIDP in a cohort of HIV-infected and HIV-uninfected patients
      Kaminie Moodley, Pierre L.A. Bill, Vinod Bhagu Patel

  8. Bossuyt, Xavier

    1. Open Access
      Negative commercial screening test for paraneoplastic antibodies in a case of opsoclonus
      Nicolas Vandenbussche, Catherine Cassiman, Maarten Schrooten, Benjamin Gille, Xavier Bossuyt, Thierry Vincent, Philip Van Damme, Koen Poesen

  9. Bsteh, Gabriel

    1. Open Access
      Severe early natalizumab-associated PML in MS: Effective control of PML-IRIS with maraviroc
      Gabriel Bsteh, Michael Auer, Sarah Iglseder, Lisa-Maria Walchhofer, Dietmar Langenscheidt, Stefan Koppi, Gabriele Schauer-Maurer, Guenther Stockhammer, Thomas Berger

  10. Buecher, Bruno

    1. Open Access
      Paraneoplastic cerebellar degeneration associated with anti-ITPR1 antibodies
      Giulia Berzero, Yael Hacohen, Lars Komorowski, Madeleine Scharf, Caroline Dehais, Delphine Leclercq, Virginie Fourchotte, Bruno Buecher, Jérôme Honnorat, Francesc Graus, Jean-Yves Delattre, Dimitri Psimaras

C

  1. Calleja-Castaño, Patricia

    1. Open Access
      Delayed tacrolimus leukoencephalopathy, a rare and reversible cause of dementia
      Diego Barragán-Martínez, Ana Simarro-Díaz, Patricia Calleja-Castaño, Aurelio Hernández-Laín, Ana Ramos-González, Alberto Villarejo-Galende

  2. Campoverde, Alfredo

    1. Open Access
      Validity of a PCR assay in CSF for the diagnosis of neurocysticercosis
      Arturo Carpio, Alfredo Campoverde, Matthew L. Romo, Lorena García, Luis M. Piedra, Mónica Pacurucu, Nelson López, Jenner Aguilar, Sebastian López, Luis C. Vintimilla, Ana M. Toral, Pablo Peña-Tapia

  3. Capobianco, Marco

    1. Open Access
      Aquaporin-4 antibody titration in NMO patients treated with rituximabA retrospective study
      Paola Valentino, Fabiana Marnetto, Letizia Granieri, Marco Capobianco, Antonio Bertolotto

  4. Carpio, Arturo

    1. Open Access
      Validity of a PCR assay in CSF for the diagnosis of neurocysticercosis
      Arturo Carpio, Alfredo Campoverde, Matthew L. Romo, Lorena García, Luis M. Piedra, Mónica Pacurucu, Nelson López, Jenner Aguilar, Sebastian López, Luis C. Vintimilla, Ana M. Toral, Pablo Peña-Tapia

  5. Cassiman, Catherine

    1. Open Access
      Negative commercial screening test for paraneoplastic antibodies in a case of opsoclonus
      Nicolas Vandenbussche, Catherine Cassiman, Maarten Schrooten, Benjamin Gille, Xavier Bossuyt, Thierry Vincent, Philip Van Damme, Koen Poesen

  6. Castro, Azucena

    1. Open Access
      Metabolomic signatures associated with disease severity in multiple sclerosis
      Pablo Villoslada, Cristina Alonso, Ion Agirrezabal, Ekaterina Kotelnikova, Irati Zubizarreta, Irene Pulido-Valdeolivas, Albert Saiz, Manuel Comabella, Xavier Montalban, Luisa Villar, Jose Carlos Alvarez-Cermeño, Oscar Fernández, Roberto Alvarez-Lafuente, Rafael Arroyo, Azucena Castro

  7. Comabella, Manuel

    1. Open Access
      Metabolomic signatures associated with disease severity in multiple sclerosis
      Pablo Villoslada, Cristina Alonso, Ion Agirrezabal, Ekaterina Kotelnikova, Irati Zubizarreta, Irene Pulido-Valdeolivas, Albert Saiz, Manuel Comabella, Xavier Montalban, Luisa Villar, Jose Carlos Alvarez-Cermeño, Oscar Fernández, Roberto Alvarez-Lafuente, Rafael Arroyo, Azucena Castro

D

  1. Dalmau, Josep

    1. Open Access
      MOG antibodies, cortical encephalitis, and more food for thought studies
      Josep Dalmau

  2. Davis, Mat D.

    1. Open Access
      Time course of glatiramer acetate efficacy in patients with RRMS in the GALA study
      Mat D. Davis, Natalia Ashtamker, Joshua R. Steinerman, Volker Knappertz

  3. Dehais, Caroline

    1. Open Access
      Paraneoplastic cerebellar degeneration associated with anti-ITPR1 antibodies
      Giulia Berzero, Yael Hacohen, Lars Komorowski, Madeleine Scharf, Caroline Dehais, Delphine Leclercq, Virginie Fourchotte, Bruno Buecher, Jérôme Honnorat, Francesc Graus, Jean-Yves Delattre, Dimitri Psimaras

  4. Delattre, Jean-Yves

    1. Open Access
      Paraneoplastic cerebellar degeneration associated with anti-ITPR1 antibodies
      Giulia Berzero, Yael Hacohen, Lars Komorowski, Madeleine Scharf, Caroline Dehais, Delphine Leclercq, Virginie Fourchotte, Bruno Buecher, Jérôme Honnorat, Francesc Graus, Jean-Yves Delattre, Dimitri Psimaras

  5. Dobson, Ruth

    1. Open Access
      Epstein-Barr–negative MS: a true phenomenon?
      Ruth Dobson, Jens Kuhle, Jaap Middeldorp, Gavin Giovannoni

  6. Duddy, Martin

    1. Open Access
      An observational study of alemtuzumab following fingolimod for multiple sclerosis
      Mark Willis, Owen Pearson, Zsolt Illes, Tobias Sejbaek, Christian Nielsen, Martin Duddy, Kate Petheram, Caspar van Munster, Joep Killestein, Clas Malmeström, Emma Tallantyre, Neil Robertson

E

  1. Elias-Hamp, Birte

    1. Open Access
      Maraviroc as possible treatment for PML-IRIS in natalizumab-treated patients with MS
      Sibylle C. Hodecker, Klarissa H. Stürner, Veit Becker, Birte Elias-Hamp, Brigitte Holst, Manuel A. Friese, Christoph Heesen

F

  1. Fernández, Oscar

    1. Open Access
      Metabolomic signatures associated with disease severity in multiple sclerosis
      Pablo Villoslada, Cristina Alonso, Ion Agirrezabal, Ekaterina Kotelnikova, Irati Zubizarreta, Irene Pulido-Valdeolivas, Albert Saiz, Manuel Comabella, Xavier Montalban, Luisa Villar, Jose Carlos Alvarez-Cermeño, Oscar Fernández, Roberto Alvarez-Lafuente, Rafael Arroyo, Azucena Castro

  2. Fourchotte, Virginie

    1. Open Access
      Paraneoplastic cerebellar degeneration associated with anti-ITPR1 antibodies
      Giulia Berzero, Yael Hacohen, Lars Komorowski, Madeleine Scharf, Caroline Dehais, Delphine Leclercq, Virginie Fourchotte, Bruno Buecher, Jérôme Honnorat, Francesc Graus, Jean-Yves Delattre, Dimitri Psimaras

  3. Friese, Manuel A.

    1. Open Access
      Ruxolitinib treatment in a patient with neuromyelitis optica: A case report
      Sibylle C. Hodecker, Jan-Patrick Stellmann, Sina C. Rosenkranz, Kim Young, Brigitte Holst, Manuel A. Friese, Christoph Heesen
    2. Open Access
      Maraviroc as possible treatment for PML-IRIS in natalizumab-treated patients with MS
      Sibylle C. Hodecker, Klarissa H. Stürner, Veit Becker, Birte Elias-Hamp, Brigitte Holst, Manuel A. Friese, Christoph Heesen

  4. Fujihara, Kazuo

    1. Open Access
      MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsy
      Ryo Ogawa, Ichiro Nakashima, Toshiyuki Takahashi, Kimihiko Kaneko, Tetsuya Akaishi, Yoshiki Takai, Douglas Kazutoshi Sato, Shuhei Nishiyama, Tatsuro Misu, Hiroshi Kuroda, Masashi Aoki, Kazuo Fujihara

G

  1. García, Lorena

    1. Open Access
      Validity of a PCR assay in CSF for the diagnosis of neurocysticercosis
      Arturo Carpio, Alfredo Campoverde, Matthew L. Romo, Lorena García, Luis M. Piedra, Mónica Pacurucu, Nelson López, Jenner Aguilar, Sebastian López, Luis C. Vintimilla, Ana M. Toral, Pablo Peña-Tapia

  2. Gille, Benjamin

    1. Open Access
      Negative commercial screening test for paraneoplastic antibodies in a case of opsoclonus
      Nicolas Vandenbussche, Catherine Cassiman, Maarten Schrooten, Benjamin Gille, Xavier Bossuyt, Thierry Vincent, Philip Van Damme, Koen Poesen

  3. Giovannoni, Gavin

    1. Open Access
      Epstein-Barr–negative MS: a true phenomenon?
      Ruth Dobson, Jens Kuhle, Jaap Middeldorp, Gavin Giovannoni

  4. Granieri, Letizia

    1. Open Access
      Aquaporin-4 antibody titration in NMO patients treated with rituximabA retrospective study
      Paola Valentino, Fabiana Marnetto, Letizia Granieri, Marco Capobianco, Antonio Bertolotto

  5. Graus, Francesc

    1. Open Access
      Paraneoplastic cerebellar degeneration associated with anti-ITPR1 antibodies
      Giulia Berzero, Yael Hacohen, Lars Komorowski, Madeleine Scharf, Caroline Dehais, Delphine Leclercq, Virginie Fourchotte, Bruno Buecher, Jérôme Honnorat, Francesc Graus, Jean-Yves Delattre, Dimitri Psimaras

H

  1. Hacohen, Yael

    1. Open Access
      Paraneoplastic cerebellar degeneration associated with anti-ITPR1 antibodies
      Giulia Berzero, Yael Hacohen, Lars Komorowski, Madeleine Scharf, Caroline Dehais, Delphine Leclercq, Virginie Fourchotte, Bruno Buecher, Jérôme Honnorat, Francesc Graus, Jean-Yves Delattre, Dimitri Psimaras

  2. Heesen, Christoph

    1. Open Access
      Ruxolitinib treatment in a patient with neuromyelitis optica: A case report
      Sibylle C. Hodecker, Jan-Patrick Stellmann, Sina C. Rosenkranz, Kim Young, Brigitte Holst, Manuel A. Friese, Christoph Heesen
    2. Open Access
      Maraviroc as possible treatment for PML-IRIS in natalizumab-treated patients with MS
      Sibylle C. Hodecker, Klarissa H. Stürner, Veit Becker, Birte Elias-Hamp, Brigitte Holst, Manuel A. Friese, Christoph Heesen

  3. Hernández-Laín, Aurelio

    1. Open Access
      Delayed tacrolimus leukoencephalopathy, a rare and reversible cause of dementia
      Diego Barragán-Martínez, Ana Simarro-Díaz, Patricia Calleja-Castaño, Aurelio Hernández-Laín, Ana Ramos-González, Alberto Villarejo-Galende

  4. Hodecker, Sibylle C.

    1. Open Access
      Ruxolitinib treatment in a patient with neuromyelitis optica: A case report
      Sibylle C. Hodecker, Jan-Patrick Stellmann, Sina C. Rosenkranz, Kim Young, Brigitte Holst, Manuel A. Friese, Christoph Heesen
    2. Open Access
      Maraviroc as possible treatment for PML-IRIS in natalizumab-treated patients with MS
      Sibylle C. Hodecker, Klarissa H. Stürner, Veit Becker, Birte Elias-Hamp, Brigitte Holst, Manuel A. Friese, Christoph Heesen

  5. Holst, Brigitte

    1. Open Access
      Ruxolitinib treatment in a patient with neuromyelitis optica: A case report
      Sibylle C. Hodecker, Jan-Patrick Stellmann, Sina C. Rosenkranz, Kim Young, Brigitte Holst, Manuel A. Friese, Christoph Heesen
    2. Open Access
      Maraviroc as possible treatment for PML-IRIS in natalizumab-treated patients with MS
      Sibylle C. Hodecker, Klarissa H. Stürner, Veit Becker, Birte Elias-Hamp, Brigitte Holst, Manuel A. Friese, Christoph Heesen

  6. Honnorat, Jérôme

    1. Open Access
      Paraneoplastic cerebellar degeneration associated with anti-ITPR1 antibodies
      Giulia Berzero, Yael Hacohen, Lars Komorowski, Madeleine Scharf, Caroline Dehais, Delphine Leclercq, Virginie Fourchotte, Bruno Buecher, Jérôme Honnorat, Francesc Graus, Jean-Yves Delattre, Dimitri Psimaras

I

  1. Iglseder, Sarah

    1. Open Access
      Severe early natalizumab-associated PML in MS: Effective control of PML-IRIS with maraviroc
      Gabriel Bsteh, Michael Auer, Sarah Iglseder, Lisa-Maria Walchhofer, Dietmar Langenscheidt, Stefan Koppi, Gabriele Schauer-Maurer, Guenther Stockhammer, Thomas Berger

  2. Illes, Zsolt

    1. Open Access
      An observational study of alemtuzumab following fingolimod for multiple sclerosis
      Mark Willis, Owen Pearson, Zsolt Illes, Tobias Sejbaek, Christian Nielsen, Martin Duddy, Kate Petheram, Caspar van Munster, Joep Killestein, Clas Malmeström, Emma Tallantyre, Neil Robertson

K

  1. Kaneko, Kimihiko

    1. Open Access
      MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsy
      Ryo Ogawa, Ichiro Nakashima, Toshiyuki Takahashi, Kimihiko Kaneko, Tetsuya Akaishi, Yoshiki Takai, Douglas Kazutoshi Sato, Shuhei Nishiyama, Tatsuro Misu, Hiroshi Kuroda, Masashi Aoki, Kazuo Fujihara

  2. Killestein, Joep

    1. Open Access
      An observational study of alemtuzumab following fingolimod for multiple sclerosis
      Mark Willis, Owen Pearson, Zsolt Illes, Tobias Sejbaek, Christian Nielsen, Martin Duddy, Kate Petheram, Caspar van Munster, Joep Killestein, Clas Malmeström, Emma Tallantyre, Neil Robertson

  3. Knappertz, Volker

    1. Open Access
      Time course of glatiramer acetate efficacy in patients with RRMS in the GALA study
      Mat D. Davis, Natalia Ashtamker, Joshua R. Steinerman, Volker Knappertz

  4. Komorowski, Lars

    1. Open Access
      Paraneoplastic cerebellar degeneration associated with anti-ITPR1 antibodies
      Giulia Berzero, Yael Hacohen, Lars Komorowski, Madeleine Scharf, Caroline Dehais, Delphine Leclercq, Virginie Fourchotte, Bruno Buecher, Jérôme Honnorat, Francesc Graus, Jean-Yves Delattre, Dimitri Psimaras

  5. Koppi, Stefan

    1. Open Access
      Severe early natalizumab-associated PML in MS: Effective control of PML-IRIS with maraviroc
      Gabriel Bsteh, Michael Auer, Sarah Iglseder, Lisa-Maria Walchhofer, Dietmar Langenscheidt, Stefan Koppi, Gabriele Schauer-Maurer, Guenther Stockhammer, Thomas Berger

  6. Kotelnikova, Ekaterina

    1. Open Access
      Metabolomic signatures associated with disease severity in multiple sclerosis
      Pablo Villoslada, Cristina Alonso, Ion Agirrezabal, Ekaterina Kotelnikova, Irati Zubizarreta, Irene Pulido-Valdeolivas, Albert Saiz, Manuel Comabella, Xavier Montalban, Luisa Villar, Jose Carlos Alvarez-Cermeño, Oscar Fernández, Roberto Alvarez-Lafuente, Rafael Arroyo, Azucena Castro

  7. Kuhle, Jens

    1. Open Access
      Epstein-Barr–negative MS: a true phenomenon?
      Ruth Dobson, Jens Kuhle, Jaap Middeldorp, Gavin Giovannoni

  8. Kuroda, Hiroshi

    1. Open Access
      MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsy
      Ryo Ogawa, Ichiro Nakashima, Toshiyuki Takahashi, Kimihiko Kaneko, Tetsuya Akaishi, Yoshiki Takai, Douglas Kazutoshi Sato, Shuhei Nishiyama, Tatsuro Misu, Hiroshi Kuroda, Masashi Aoki, Kazuo Fujihara

L

  1. Langenscheidt, Dietmar

    1. Open Access
      Severe early natalizumab-associated PML in MS: Effective control of PML-IRIS with maraviroc
      Gabriel Bsteh, Michael Auer, Sarah Iglseder, Lisa-Maria Walchhofer, Dietmar Langenscheidt, Stefan Koppi, Gabriele Schauer-Maurer, Guenther Stockhammer, Thomas Berger

  2. Leclercq, Delphine

    1. Open Access
      Paraneoplastic cerebellar degeneration associated with anti-ITPR1 antibodies
      Giulia Berzero, Yael Hacohen, Lars Komorowski, Madeleine Scharf, Caroline Dehais, Delphine Leclercq, Virginie Fourchotte, Bruno Buecher, Jérôme Honnorat, Francesc Graus, Jean-Yves Delattre, Dimitri Psimaras

  3. López, Nelson

    1. Open Access
      Validity of a PCR assay in CSF for the diagnosis of neurocysticercosis
      Arturo Carpio, Alfredo Campoverde, Matthew L. Romo, Lorena García, Luis M. Piedra, Mónica Pacurucu, Nelson López, Jenner Aguilar, Sebastian López, Luis C. Vintimilla, Ana M. Toral, Pablo Peña-Tapia

  4. López, Sebastian

    1. Open Access
      Validity of a PCR assay in CSF for the diagnosis of neurocysticercosis
      Arturo Carpio, Alfredo Campoverde, Matthew L. Romo, Lorena García, Luis M. Piedra, Mónica Pacurucu, Nelson López, Jenner Aguilar, Sebastian López, Luis C. Vintimilla, Ana M. Toral, Pablo Peña-Tapia

M

  1. Malmeström, Clas

    1. Open Access
      An observational study of alemtuzumab following fingolimod for multiple sclerosis
      Mark Willis, Owen Pearson, Zsolt Illes, Tobias Sejbaek, Christian Nielsen, Martin Duddy, Kate Petheram, Caspar van Munster, Joep Killestein, Clas Malmeström, Emma Tallantyre, Neil Robertson

  2. Marnetto, Fabiana

    1. Open Access
      Aquaporin-4 antibody titration in NMO patients treated with rituximabA retrospective study
      Paola Valentino, Fabiana Marnetto, Letizia Granieri, Marco Capobianco, Antonio Bertolotto

  3. McGee, Nathan R.

    1. Open Access
      Characteristics and pharmacodynamics of severe neuroinflammation in a child with neurolupus
      Michael R. Pranzatelli, Nathan R. McGee, Zeng Y. Wang, Brajesh K. Agrawal

  4. Middeldorp, Jaap

    1. Open Access
      Epstein-Barr–negative MS: a true phenomenon?
      Ruth Dobson, Jens Kuhle, Jaap Middeldorp, Gavin Giovannoni

  5. Misu, Tatsuro

    1. Open Access
      MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsy
      Ryo Ogawa, Ichiro Nakashima, Toshiyuki Takahashi, Kimihiko Kaneko, Tetsuya Akaishi, Yoshiki Takai, Douglas Kazutoshi Sato, Shuhei Nishiyama, Tatsuro Misu, Hiroshi Kuroda, Masashi Aoki, Kazuo Fujihara

  6. Montalban, Xavier

    1. Open Access
      Metabolomic signatures associated with disease severity in multiple sclerosis
      Pablo Villoslada, Cristina Alonso, Ion Agirrezabal, Ekaterina Kotelnikova, Irati Zubizarreta, Irene Pulido-Valdeolivas, Albert Saiz, Manuel Comabella, Xavier Montalban, Luisa Villar, Jose Carlos Alvarez-Cermeño, Oscar Fernández, Roberto Alvarez-Lafuente, Rafael Arroyo, Azucena Castro

  7. Moodley, Kaminie

    1. Open Access
      A comparative study of CIDP in a cohort of HIV-infected and HIV-uninfected patients
      Kaminie Moodley, Pierre L.A. Bill, Vinod Bhagu Patel

N

  1. Nakashima, Ichiro

    1. Open Access
      MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsy
      Ryo Ogawa, Ichiro Nakashima, Toshiyuki Takahashi, Kimihiko Kaneko, Tetsuya Akaishi, Yoshiki Takai, Douglas Kazutoshi Sato, Shuhei Nishiyama, Tatsuro Misu, Hiroshi Kuroda, Masashi Aoki, Kazuo Fujihara

  2. Nielsen, Christian

    1. Open Access
      An observational study of alemtuzumab following fingolimod for multiple sclerosis
      Mark Willis, Owen Pearson, Zsolt Illes, Tobias Sejbaek, Christian Nielsen, Martin Duddy, Kate Petheram, Caspar van Munster, Joep Killestein, Clas Malmeström, Emma Tallantyre, Neil Robertson

  3. Nishiyama, Shuhei

    1. Open Access
      MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsy
      Ryo Ogawa, Ichiro Nakashima, Toshiyuki Takahashi, Kimihiko Kaneko, Tetsuya Akaishi, Yoshiki Takai, Douglas Kazutoshi Sato, Shuhei Nishiyama, Tatsuro Misu, Hiroshi Kuroda, Masashi Aoki, Kazuo Fujihara

O

  1. Ogawa, Ryo

    1. Open Access
      MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsy
      Ryo Ogawa, Ichiro Nakashima, Toshiyuki Takahashi, Kimihiko Kaneko, Tetsuya Akaishi, Yoshiki Takai, Douglas Kazutoshi Sato, Shuhei Nishiyama, Tatsuro Misu, Hiroshi Kuroda, Masashi Aoki, Kazuo Fujihara

P

  1. Pacurucu, Mónica

    1. Open Access
      Validity of a PCR assay in CSF for the diagnosis of neurocysticercosis
      Arturo Carpio, Alfredo Campoverde, Matthew L. Romo, Lorena García, Luis M. Piedra, Mónica Pacurucu, Nelson López, Jenner Aguilar, Sebastian López, Luis C. Vintimilla, Ana M. Toral, Pablo Peña-Tapia

  2. Patel, Vinod Bhagu

    1. Open Access
      A comparative study of CIDP in a cohort of HIV-infected and HIV-uninfected patients
      Kaminie Moodley, Pierre L.A. Bill, Vinod Bhagu Patel

  3. Pearson, Owen

    1. Open Access
      An observational study of alemtuzumab following fingolimod for multiple sclerosis
      Mark Willis, Owen Pearson, Zsolt Illes, Tobias Sejbaek, Christian Nielsen, Martin Duddy, Kate Petheram, Caspar van Munster, Joep Killestein, Clas Malmeström, Emma Tallantyre, Neil Robertson

  4. Peña-Tapia, Pablo

    1. Open Access
      Validity of a PCR assay in CSF for the diagnosis of neurocysticercosis
      Arturo Carpio, Alfredo Campoverde, Matthew L. Romo, Lorena García, Luis M. Piedra, Mónica Pacurucu, Nelson López, Jenner Aguilar, Sebastian López, Luis C. Vintimilla, Ana M. Toral, Pablo Peña-Tapia

  5. Petheram, Kate

    1. Open Access
      An observational study of alemtuzumab following fingolimod for multiple sclerosis
      Mark Willis, Owen Pearson, Zsolt Illes, Tobias Sejbaek, Christian Nielsen, Martin Duddy, Kate Petheram, Caspar van Munster, Joep Killestein, Clas Malmeström, Emma Tallantyre, Neil Robertson

  6. Piedra, Luis M.

    1. Open Access
      Validity of a PCR assay in CSF for the diagnosis of neurocysticercosis
      Arturo Carpio, Alfredo Campoverde, Matthew L. Romo, Lorena García, Luis M. Piedra, Mónica Pacurucu, Nelson López, Jenner Aguilar, Sebastian López, Luis C. Vintimilla, Ana M. Toral, Pablo Peña-Tapia

  7. Poesen, Koen

    1. Open Access
      Negative commercial screening test for paraneoplastic antibodies in a case of opsoclonus
      Nicolas Vandenbussche, Catherine Cassiman, Maarten Schrooten, Benjamin Gille, Xavier Bossuyt, Thierry Vincent, Philip Van Damme, Koen Poesen

  8. Pranzatelli, Michael R.

    1. Open Access
      Characteristics and pharmacodynamics of severe neuroinflammation in a child with neurolupus
      Michael R. Pranzatelli, Nathan R. McGee, Zeng Y. Wang, Brajesh K. Agrawal

  9. Psimaras, Dimitri

    1. Open Access
      Paraneoplastic cerebellar degeneration associated with anti-ITPR1 antibodies
      Giulia Berzero, Yael Hacohen, Lars Komorowski, Madeleine Scharf, Caroline Dehais, Delphine Leclercq, Virginie Fourchotte, Bruno Buecher, Jérôme Honnorat, Francesc Graus, Jean-Yves Delattre, Dimitri Psimaras

  10. Pulido-Valdeolivas, Irene

    1. Open Access
      Metabolomic signatures associated with disease severity in multiple sclerosis
      Pablo Villoslada, Cristina Alonso, Ion Agirrezabal, Ekaterina Kotelnikova, Irati Zubizarreta, Irene Pulido-Valdeolivas, Albert Saiz, Manuel Comabella, Xavier Montalban, Luisa Villar, Jose Carlos Alvarez-Cermeño, Oscar Fernández, Roberto Alvarez-Lafuente, Rafael Arroyo, Azucena Castro

R

  1. Ramos-González, Ana

    1. Open Access
      Delayed tacrolimus leukoencephalopathy, a rare and reversible cause of dementia
      Diego Barragán-Martínez, Ana Simarro-Díaz, Patricia Calleja-Castaño, Aurelio Hernández-Laín, Ana Ramos-González, Alberto Villarejo-Galende

  2. Robertson, Neil

    1. Open Access
      An observational study of alemtuzumab following fingolimod for multiple sclerosis
      Mark Willis, Owen Pearson, Zsolt Illes, Tobias Sejbaek, Christian Nielsen, Martin Duddy, Kate Petheram, Caspar van Munster, Joep Killestein, Clas Malmeström, Emma Tallantyre, Neil Robertson

  3. Romo, Matthew L.

    1. Open Access
      Validity of a PCR assay in CSF for the diagnosis of neurocysticercosis
      Arturo Carpio, Alfredo Campoverde, Matthew L. Romo, Lorena García, Luis M. Piedra, Mónica Pacurucu, Nelson López, Jenner Aguilar, Sebastian López, Luis C. Vintimilla, Ana M. Toral, Pablo Peña-Tapia

  4. Rosenkranz, Sina C.

    1. Open Access
      Ruxolitinib treatment in a patient with neuromyelitis optica: A case report
      Sibylle C. Hodecker, Jan-Patrick Stellmann, Sina C. Rosenkranz, Kim Young, Brigitte Holst, Manuel A. Friese, Christoph Heesen

S

  1. Saiz, Albert

    1. Open Access
      Metabolomic signatures associated with disease severity in multiple sclerosis
      Pablo Villoslada, Cristina Alonso, Ion Agirrezabal, Ekaterina Kotelnikova, Irati Zubizarreta, Irene Pulido-Valdeolivas, Albert Saiz, Manuel Comabella, Xavier Montalban, Luisa Villar, Jose Carlos Alvarez-Cermeño, Oscar Fernández, Roberto Alvarez-Lafuente, Rafael Arroyo, Azucena Castro

  2. Sato, Douglas Kazutoshi

    1. Open Access
      MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsy
      Ryo Ogawa, Ichiro Nakashima, Toshiyuki Takahashi, Kimihiko Kaneko, Tetsuya Akaishi, Yoshiki Takai, Douglas Kazutoshi Sato, Shuhei Nishiyama, Tatsuro Misu, Hiroshi Kuroda, Masashi Aoki, Kazuo Fujihara

  3. Scharf, Madeleine

    1. Open Access
      Paraneoplastic cerebellar degeneration associated with anti-ITPR1 antibodies
      Giulia Berzero, Yael Hacohen, Lars Komorowski, Madeleine Scharf, Caroline Dehais, Delphine Leclercq, Virginie Fourchotte, Bruno Buecher, Jérôme Honnorat, Francesc Graus, Jean-Yves Delattre, Dimitri Psimaras

  4. Schauer-Maurer, Gabriele

    1. Open Access
      Severe early natalizumab-associated PML in MS: Effective control of PML-IRIS with maraviroc
      Gabriel Bsteh, Michael Auer, Sarah Iglseder, Lisa-Maria Walchhofer, Dietmar Langenscheidt, Stefan Koppi, Gabriele Schauer-Maurer, Guenther Stockhammer, Thomas Berger

  5. Schrooten, Maarten

    1. Open Access
      Negative commercial screening test for paraneoplastic antibodies in a case of opsoclonus
      Nicolas Vandenbussche, Catherine Cassiman, Maarten Schrooten, Benjamin Gille, Xavier Bossuyt, Thierry Vincent, Philip Van Damme, Koen Poesen

  6. Sejbaek, Tobias

    1. Open Access
      An observational study of alemtuzumab following fingolimod for multiple sclerosis
      Mark Willis, Owen Pearson, Zsolt Illes, Tobias Sejbaek, Christian Nielsen, Martin Duddy, Kate Petheram, Caspar van Munster, Joep Killestein, Clas Malmeström, Emma Tallantyre, Neil Robertson

  7. Simarro-Díaz, Ana

    1. Open Access
      Delayed tacrolimus leukoencephalopathy, a rare and reversible cause of dementia
      Diego Barragán-Martínez, Ana Simarro-Díaz, Patricia Calleja-Castaño, Aurelio Hernández-Laín, Ana Ramos-González, Alberto Villarejo-Galende

  8. Steiner, Israel

    1. Open Access
      Maraviroc in PML-IRISA separate ball game under HIV infection and natalizumab?
      Israel Steiner, Felix Benninger

  9. Steinerman, Joshua R.

    1. Open Access
      Time course of glatiramer acetate efficacy in patients with RRMS in the GALA study
      Mat D. Davis, Natalia Ashtamker, Joshua R. Steinerman, Volker Knappertz

  10. Stellmann, Jan-Patrick

    1. Open Access
      Ruxolitinib treatment in a patient with neuromyelitis optica: A case report
      Sibylle C. Hodecker, Jan-Patrick Stellmann, Sina C. Rosenkranz, Kim Young, Brigitte Holst, Manuel A. Friese, Christoph Heesen

  11. Stockhammer, Guenther

    1. Open Access
      Severe early natalizumab-associated PML in MS: Effective control of PML-IRIS with maraviroc
      Gabriel Bsteh, Michael Auer, Sarah Iglseder, Lisa-Maria Walchhofer, Dietmar Langenscheidt, Stefan Koppi, Gabriele Schauer-Maurer, Guenther Stockhammer, Thomas Berger

  12. Stürner, Klarissa H.

    1. Open Access
      Maraviroc as possible treatment for PML-IRIS in natalizumab-treated patients with MS
      Sibylle C. Hodecker, Klarissa H. Stürner, Veit Becker, Birte Elias-Hamp, Brigitte Holst, Manuel A. Friese, Christoph Heesen

T

  1. Takahashi, Toshiyuki

    1. Open Access
      MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsy
      Ryo Ogawa, Ichiro Nakashima, Toshiyuki Takahashi, Kimihiko Kaneko, Tetsuya Akaishi, Yoshiki Takai, Douglas Kazutoshi Sato, Shuhei Nishiyama, Tatsuro Misu, Hiroshi Kuroda, Masashi Aoki, Kazuo Fujihara

  2. Takai, Yoshiki

    1. Open Access
      MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsy
      Ryo Ogawa, Ichiro Nakashima, Toshiyuki Takahashi, Kimihiko Kaneko, Tetsuya Akaishi, Yoshiki Takai, Douglas Kazutoshi Sato, Shuhei Nishiyama, Tatsuro Misu, Hiroshi Kuroda, Masashi Aoki, Kazuo Fujihara

  3. Tallantyre, Emma

    1. Open Access
      An observational study of alemtuzumab following fingolimod for multiple sclerosis
      Mark Willis, Owen Pearson, Zsolt Illes, Tobias Sejbaek, Christian Nielsen, Martin Duddy, Kate Petheram, Caspar van Munster, Joep Killestein, Clas Malmeström, Emma Tallantyre, Neil Robertson

  4. Toral, Ana M.

    1. Open Access
      Validity of a PCR assay in CSF for the diagnosis of neurocysticercosis
      Arturo Carpio, Alfredo Campoverde, Matthew L. Romo, Lorena García, Luis M. Piedra, Mónica Pacurucu, Nelson López, Jenner Aguilar, Sebastian López, Luis C. Vintimilla, Ana M. Toral, Pablo Peña-Tapia

V

  1. Valentino, Paola

    1. Open Access
      Aquaporin-4 antibody titration in NMO patients treated with rituximabA retrospective study
      Paola Valentino, Fabiana Marnetto, Letizia Granieri, Marco Capobianco, Antonio Bertolotto

  2. Van Damme, Philip

    1. Open Access
      Negative commercial screening test for paraneoplastic antibodies in a case of opsoclonus
      Nicolas Vandenbussche, Catherine Cassiman, Maarten Schrooten, Benjamin Gille, Xavier Bossuyt, Thierry Vincent, Philip Van Damme, Koen Poesen

  3. Vandenbussche, Nicolas

    1. Open Access
      Negative commercial screening test for paraneoplastic antibodies in a case of opsoclonus
      Nicolas Vandenbussche, Catherine Cassiman, Maarten Schrooten, Benjamin Gille, Xavier Bossuyt, Thierry Vincent, Philip Van Damme, Koen Poesen

  4. van Munster, Caspar

    1. Open Access
      An observational study of alemtuzumab following fingolimod for multiple sclerosis
      Mark Willis, Owen Pearson, Zsolt Illes, Tobias Sejbaek, Christian Nielsen, Martin Duddy, Kate Petheram, Caspar van Munster, Joep Killestein, Clas Malmeström, Emma Tallantyre, Neil Robertson

  5. Villar, Luisa

    1. Open Access
      Metabolomic signatures associated with disease severity in multiple sclerosis
      Pablo Villoslada, Cristina Alonso, Ion Agirrezabal, Ekaterina Kotelnikova, Irati Zubizarreta, Irene Pulido-Valdeolivas, Albert Saiz, Manuel Comabella, Xavier Montalban, Luisa Villar, Jose Carlos Alvarez-Cermeño, Oscar Fernández, Roberto Alvarez-Lafuente, Rafael Arroyo, Azucena Castro

  6. Villarejo-Galende, Alberto

    1. Open Access
      Delayed tacrolimus leukoencephalopathy, a rare and reversible cause of dementia
      Diego Barragán-Martínez, Ana Simarro-Díaz, Patricia Calleja-Castaño, Aurelio Hernández-Laín, Ana Ramos-González, Alberto Villarejo-Galende

  7. Villoslada, Pablo

    1. Open Access
      Metabolomic signatures associated with disease severity in multiple sclerosis
      Pablo Villoslada, Cristina Alonso, Ion Agirrezabal, Ekaterina Kotelnikova, Irati Zubizarreta, Irene Pulido-Valdeolivas, Albert Saiz, Manuel Comabella, Xavier Montalban, Luisa Villar, Jose Carlos Alvarez-Cermeño, Oscar Fernández, Roberto Alvarez-Lafuente, Rafael Arroyo, Azucena Castro

  8. Vincent, Thierry

    1. Open Access
      Negative commercial screening test for paraneoplastic antibodies in a case of opsoclonus
      Nicolas Vandenbussche, Catherine Cassiman, Maarten Schrooten, Benjamin Gille, Xavier Bossuyt, Thierry Vincent, Philip Van Damme, Koen Poesen

  9. Vintimilla, Luis C.

    1. Open Access
      Validity of a PCR assay in CSF for the diagnosis of neurocysticercosis
      Arturo Carpio, Alfredo Campoverde, Matthew L. Romo, Lorena García, Luis M. Piedra, Mónica Pacurucu, Nelson López, Jenner Aguilar, Sebastian López, Luis C. Vintimilla, Ana M. Toral, Pablo Peña-Tapia

W

  1. Walchhofer, Lisa-Maria

    1. Open Access
      Severe early natalizumab-associated PML in MS: Effective control of PML-IRIS with maraviroc
      Gabriel Bsteh, Michael Auer, Sarah Iglseder, Lisa-Maria Walchhofer, Dietmar Langenscheidt, Stefan Koppi, Gabriele Schauer-Maurer, Guenther Stockhammer, Thomas Berger

  2. Wang, Zeng Y.

    1. Open Access
      Characteristics and pharmacodynamics of severe neuroinflammation in a child with neurolupus
      Michael R. Pranzatelli, Nathan R. McGee, Zeng Y. Wang, Brajesh K. Agrawal

  3. Willis, Mark

    1. Open Access
      An observational study of alemtuzumab following fingolimod for multiple sclerosis
      Mark Willis, Owen Pearson, Zsolt Illes, Tobias Sejbaek, Christian Nielsen, Martin Duddy, Kate Petheram, Caspar van Munster, Joep Killestein, Clas Malmeström, Emma Tallantyre, Neil Robertson

Y

  1. Young, Kim

    1. Open Access
      Ruxolitinib treatment in a patient with neuromyelitis optica: A case report
      Sibylle C. Hodecker, Jan-Patrick Stellmann, Sina C. Rosenkranz, Kim Young, Brigitte Holst, Manuel A. Friese, Christoph Heesen

Z

  1. Zubizarreta, Irati

    1. Open Access
      Metabolomic signatures associated with disease severity in multiple sclerosis
      Pablo Villoslada, Cristina Alonso, Ion Agirrezabal, Ekaterina Kotelnikova, Irati Zubizarreta, Irene Pulido-Valdeolivas, Albert Saiz, Manuel Comabella, Xavier Montalban, Luisa Villar, Jose Carlos Alvarez-Cermeño, Oscar Fernández, Roberto Alvarez-Lafuente, Rafael Arroyo, Azucena Castro
Back to top
Neurology - Neuroimmunology Neuroinflammation: 4 (2)
Subscribe to e-Alerts
RSS
Advertisement
Advertisement